Skip to main content
Top
Published in: Clinical Rheumatology 3/2016

01-03-2016 | Case Based Review

Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature

Authors: Yi Liu, Ding-Rong Zhong, Pei-Ran Zhou, Fang Lv, Dou-Dou Ma, Wei-Bo Xia, Yan Jiang, Ou Wang, Xiao-Ping Xing, Mei Li

Published in: Clinical Rheumatology | Issue 3/2016

Login to get access

Abstract

Gorham-Stout disease (GSD) is an exceedingly rare disease characterized by progressive osteolysis and angiomatosis. We investigate the features of this disease and evaluate the effects of bisphosphonates (BPs) on it. The clinical, radiological, and pathological characteristics of 12 patients diagnosed with GSD were summarized. Immunohistochemical staining with specific lymphatic endothelial markers (D2-40), vascular markers (CD 31, CD 34), and vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 3 (VEGFR-3) was performed in specimens of bone biopsy. Patients were treated with either BPs or conjunction therapy of radiation and BPs. The effects of BPs were evaluated by the change of radiological progression, bone mineral density (BMD) and bone turnover biomarkers. To further evaluate the prognosis, a literature review was done. Idiopathic massive osteolysis was found in all patients, including 11 polyostotic and one mono-ostotic osteolysis. Soft tissue lymphangioma was presented in four patents. Four patients were complicated with chylothorax. Endothelial cells lining the proliferative vessels were positive for CD31 and CD34 and D2-40. Mild expression of VEGF and VEGFR-3 was also revealed. Stabilization in osteolysis and improvement in BMD were observed after single therapy with BPs or combined with radiotherapy. High mortality rate was found in patients with chylothorax. Spontaneous, progressive osteolysis is the most typical sign of GSD. BPs and radiotherapy can contribute to the clinical stabilization in bone lesion of GSD. The complicated chylothorax possibly indicates poor prognosis.
Literature
2.
go back to reference Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37:985–1004PubMed Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37:985–1004PubMed
3.
go back to reference Motamedi MH, Homauni SM, Behnia H (2003) Massive osteolysis of the mandible: a case report. J Oral Maxillofac Surg 61:957–963CrossRefPubMed Motamedi MH, Homauni SM, Behnia H (2003) Massive osteolysis of the mandible: a case report. J Oral Maxillofac Surg 61:957–963CrossRefPubMed
4.
go back to reference Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, Tsuchida Y, Morikawa A, Kuwano H (2005) Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 40:47–50CrossRef Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, Tsuchida Y, Morikawa A, Kuwano H (2005) Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 40:47–50CrossRef
5.
go back to reference Grunewald TG, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, Konovalov D, Behrends U, Schiessl J, Wörtler K, Burdach S, von Luettichau I (2010) First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 21(8):1733–1734. doi:10.1093/annonc/mdq331 CrossRefPubMed Grunewald TG, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, Konovalov D, Behrends U, Schiessl J, Wörtler K, Burdach S, von Luettichau I (2010) First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 21(8):1733–1734. doi:10.​1093/​annonc/​mdq331 CrossRefPubMed
6.
go back to reference Nir V, Guralnik L, Livnat G, Bar-Yoseph R, Hakim F, Ilivitzki A, Bentur L (2013) Propranolol as a treatment option in Gorham-Stout syndrome: a case report. Pediatr Pulmonol 49(4):417–419. doi:10.1002/ppul.22869 CrossRefPubMed Nir V, Guralnik L, Livnat G, Bar-Yoseph R, Hakim F, Ilivitzki A, Bentur L (2013) Propranolol as a treatment option in Gorham-Stout syndrome: a case report. Pediatr Pulmonol 49(4):417–419. doi:10.​1002/​ppul.​22869 CrossRefPubMed
8.
go back to reference Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024. doi:10.1002/pbc.23124 CrossRefPubMed Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024. doi:10.​1002/​pbc.​23124 CrossRefPubMed
9.
go back to reference Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55:331–343CrossRefPubMed Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55:331–343CrossRefPubMed
10.
go back to reference Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PC, Hughes D, Forsyth RG, Jackson D, Athanasou NA (2008) Lymphatics and bone. Hum Pathol 39:49–55CrossRefPubMed Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PC, Hughes D, Forsyth RG, Jackson D, Athanasou NA (2008) Lymphatics and bone. Hum Pathol 39:49–55CrossRefPubMed
11.
go back to reference Morley JE, Dawson M, Hodgkinson H, Kalk WJ (1977) Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 45:931–935CrossRefPubMed Morley JE, Dawson M, Hodgkinson H, Kalk WJ (1977) Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 45:931–935CrossRefPubMed
13.
go back to reference Heyden G, Kindblom LG, Nielsen JM (1977) Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 59:57–61PubMed Heyden G, Kindblom LG, Nielsen JM (1977) Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 59:57–61PubMed
14.
go back to reference Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G (2013) Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924. doi:10.1007/s00256-012-1565-4 CrossRefPubMed Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G (2013) Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924. doi:10.​1007/​s00256-012-1565-4 CrossRefPubMed
15.
go back to reference Tilling G, Skobowytsh B (1968) Disappearing bone disease, morbus Gorham. Report of a case. Acta Orthop Scand 39:398–406CrossRefPubMed Tilling G, Skobowytsh B (1968) Disappearing bone disease, morbus Gorham. Report of a case. Acta Orthop Scand 39:398–406CrossRefPubMed
16.
go back to reference Moller G, Gruber H, Priemel M, Werner M, Kuhlmey AS, Delling G (1999) Gorham-Stout idiopathic osteolysis—a local osteoclastic hyperactivity? Pathologe 20:177–182CrossRefPubMed Moller G, Gruber H, Priemel M, Werner M, Kuhlmey AS, Delling G (1999) Gorham-Stout idiopathic osteolysis—a local osteoclastic hyperactivity? Pathologe 20:177–182CrossRefPubMed
17.
go back to reference Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81:1893–1897PubMed Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81:1893–1897PubMed
18.
go back to reference Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21:207–218CrossRefPubMed Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21:207–218CrossRefPubMed
22.
go back to reference Cano B, Insa S, Cifrian C, Cortina H, Hernandez M (2006) Radiologic findings in Gorham-Stout syndrome. Radiologia 48:33–36CrossRefPubMed Cano B, Insa S, Cifrian C, Cortina H, Hernandez M (2006) Radiologic findings in Gorham-Stout syndrome. Radiologia 48:33–36CrossRefPubMed
23.
go back to reference Hammer F, Kenn W, Wesselmann U, Hofbauer LC, Delling G, Allolio B, Arlt W (2005) Gorham-Stout disease—stabilization during bisphosphonate treatment. J Bone Miner Res 20:350–353CrossRefPubMed Hammer F, Kenn W, Wesselmann U, Hofbauer LC, Delling G, Allolio B, Arlt W (2005) Gorham-Stout disease—stabilization during bisphosphonate treatment. J Bone Miner Res 20:350–353CrossRefPubMed
24.
go back to reference Noda M, Endo C, Hoshikawa Y, Ishibashi N, Suzuki T, Okada Y, Kondo T (2013) Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg 61:356–358. doi:10.1007/s11748-012-0130-3 CrossRefPubMed Noda M, Endo C, Hoshikawa Y, Ishibashi N, Suzuki T, Okada Y, Kondo T (2013) Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg 61:356–358. doi:10.​1007/​s11748-012-0130-3 CrossRefPubMed
25.
go back to reference Stefanidou M, Ioannidou D, Panayotides J, Tosca A (2004) Cutaneous vascular malformation associated with osteolysis or Gorham’s sign. Int J Dermatol 43:958–961CrossRefPubMed Stefanidou M, Ioannidou D, Panayotides J, Tosca A (2004) Cutaneous vascular malformation associated with osteolysis or Gorham’s sign. Int J Dermatol 43:958–961CrossRefPubMed
26.
go back to reference Tsang WM, Tong AC, Chow LT, Ng IO (2004) Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 cases. J Oral Maxillofac Surg 62:225–230CrossRefPubMed Tsang WM, Tong AC, Chow LT, Ng IO (2004) Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 cases. J Oral Maxillofac Surg 62:225–230CrossRefPubMed
27.
go back to reference Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R (2005) Treatment of Gorham’s disease with zoledronic acid. Oral Oncol 41:747–750CrossRefPubMed Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R (2005) Treatment of Gorham’s disease with zoledronic acid. Oral Oncol 41:747–750CrossRefPubMed
28.
go back to reference Escande C, Schouman T, Francoise G, Haroche J, Menard P, Piette JC, Bertrand JC, Ruhin-Poncet B (2008) Histological features and management of a mandibular Gorham disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e30–e37. doi:10.1016/j.tripleo.2008.02.028 CrossRefPubMed Escande C, Schouman T, Francoise G, Haroche J, Menard P, Piette JC, Bertrand JC, Ruhin-Poncet B (2008) Histological features and management of a mandibular Gorham disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e30–e37. doi:10.​1016/​j.​tripleo.​2008.​02.​028 CrossRefPubMed
29.
go back to reference Lehmann G, Pfeil A, Bottcher J, Kaiser WA, Fuller J, Hein G, Wolf G (2009) Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg 129:967–972. doi:10.1007/s00402-008-0742-3 CrossRefPubMed Lehmann G, Pfeil A, Bottcher J, Kaiser WA, Fuller J, Hein G, Wolf G (2009) Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg 129:967–972. doi:10.​1007/​s00402-008-0742-3 CrossRefPubMed
35.
go back to reference Zheng MW, Yang M, Qiu JX, Nan XP, Huang LY, Zhang WD, Gong L, Huang ZZ (2012) Gorham-Stout syndrome presenting in a 5-year-old girl with a successful bisphosphonate therapeutic effect. Exp Ther Med 4:449–451PubMedPubMedCentral Zheng MW, Yang M, Qiu JX, Nan XP, Huang LY, Zhang WD, Gong L, Huang ZZ (2012) Gorham-Stout syndrome presenting in a 5-year-old girl with a successful bisphosphonate therapeutic effect. Exp Ther Med 4:449–451PubMedPubMedCentral
36.
go back to reference Takamoto RM, Armstrong RG, Stanford W, Fontenelle LJ, Troxler G (1971) Chylothorax with multiple lymphangiomata of the bone. Chest 59:687–689CrossRefPubMed Takamoto RM, Armstrong RG, Stanford W, Fontenelle LJ, Troxler G (1971) Chylothorax with multiple lymphangiomata of the bone. Chest 59:687–689CrossRefPubMed
37.
go back to reference Tie ML, Poland GA, Rosenow EC (1994) Chylothorax in Gorham’s syndrome. A common complication of a rare disease. Chest 105:208–213CrossRefPubMed Tie ML, Poland GA, Rosenow EC (1994) Chylothorax in Gorham’s syndrome. A common complication of a rare disease. Chest 105:208–213CrossRefPubMed
38.
go back to reference De Seze SHA (1956) Osteolyse essentiale scapulo-thoraco-brachiale. Rev Rhum Mal Osteoartic 23(6):517–523 De Seze SHA (1956) Osteolyse essentiale scapulo-thoraco-brachiale. Rev Rhum Mal Osteoartic 23(6):517–523
39.
go back to reference Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40-B:494–501PubMed Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40-B:494–501PubMed
40.
go back to reference Koblenzer PJ, Bukowski MJ (1961) Angiomatosis (hamartomatous hem-lymphangiomatosis). Report of a case with diffuse involvement. Pediatrics 28:65–76PubMed Koblenzer PJ, Bukowski MJ (1961) Angiomatosis (hamartomatous hem-lymphangiomatosis). Report of a case with diffuse involvement. Pediatrics 28:65–76PubMed
41.
go back to reference Tucker SM (1967) Bilateral chylothorax with multiple osteolytic lesions? Generalized abnormality of lymphatic system. Proc R Soc Med 60:17–19PubMedPubMedCentral Tucker SM (1967) Bilateral chylothorax with multiple osteolytic lesions? Generalized abnormality of lymphatic system. Proc R Soc Med 60:17–19PubMedPubMedCentral
42.
go back to reference Morphis LG, Arcinue EL, Krause JR (1970) Generalized lymphangioma in infancy with chylothorax. Pediatrics 46:566–575PubMed Morphis LG, Arcinue EL, Krause JR (1970) Generalized lymphangioma in infancy with chylothorax. Pediatrics 46:566–575PubMed
43.
go back to reference Touraine RT, Balander AM (1970) Chylothorax et maladie de Gorham. Lyon Med 224:459–466PubMed Touraine RT, Balander AM (1970) Chylothorax et maladie de Gorham. Lyon Med 224:459–466PubMed
44.
go back to reference Kolpakova LV, Iaroshevskaia EN (1967) A case of massive regional osteolysis. Arkh Patol 29:75–77PubMed Kolpakova LV, Iaroshevskaia EN (1967) A case of massive regional osteolysis. Arkh Patol 29:75–77PubMed
45.
go back to reference Nozicka Z, Herout V, Fingerland A (1974) Gorham-Stout syndrome caused by hemangiolymphangioma. Cesk Patol 10:56–62PubMed Nozicka Z, Herout V, Fingerland A (1974) Gorham-Stout syndrome caused by hemangiolymphangioma. Cesk Patol 10:56–62PubMed
46.
go back to reference Choma ND, Biscotti CV, Bauer TW, Mehta AC, Licata AA (1987) Gorham’s syndrome: a case report and review of the literature. Am J Med 83:1151–1156CrossRefPubMed Choma ND, Biscotti CV, Bauer TW, Mehta AC, Licata AA (1987) Gorham’s syndrome: a case report and review of the literature. Am J Med 83:1151–1156CrossRefPubMed
47.
go back to reference Dickson GR, Mollan RA, Carr KE (1987) Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87:569–572CrossRefPubMed Dickson GR, Mollan RA, Carr KE (1987) Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87:569–572CrossRefPubMed
48.
go back to reference Joseph J, Bartal E (1987) Disappearing bone disease: a case report and review of the literature. J Pediatr Orthop 7:584–588CrossRefPubMed Joseph J, Bartal E (1987) Disappearing bone disease: a case report and review of the literature. J Pediatr Orthop 7:584–588CrossRefPubMed
49.
go back to reference Marymont JV (1987) Comparative imaging. Massive osteolysis (Gorham’s syndrome, disappearing bone disease). Clin Nucl Med 12:153–154CrossRefPubMed Marymont JV (1987) Comparative imaging. Massive osteolysis (Gorham’s syndrome, disappearing bone disease). Clin Nucl Med 12:153–154CrossRefPubMed
50.
go back to reference Lee S, Finn L, Sze RW, Perkins JA, Sie KC (2003) Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg 129:1340–1343CrossRefPubMed Lee S, Finn L, Sze RW, Perkins JA, Sie KC (2003) Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg 129:1340–1343CrossRefPubMed
51.
go back to reference Heyd R, Micke O, Surholt C, Berger B, Martini C, Fuller J, Schimpke T, Seegenschmiedt MH (2011) German Cooperative Group on Radiotherapy for Benign D. Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review. Int J Radiat Oncol Biol Phys 81:e179–e185CrossRefPubMed Heyd R, Micke O, Surholt C, Berger B, Martini C, Fuller J, Schimpke T, Seegenschmiedt MH (2011) German Cooperative Group on Radiotherapy for Benign D. Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review. Int J Radiat Oncol Biol Phys 81:e179–e185CrossRefPubMed
52.
go back to reference Pfleger A, Schwinger W, Maier A, Tauss J, Popper HH, Zach MS (2006) Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 28(4):231–233CrossRefPubMed Pfleger A, Schwinger W, Maier A, Tauss J, Popper HH, Zach MS (2006) Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 28(4):231–233CrossRefPubMed
54.
go back to reference Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, Gulhan B, Demiricin M, Kiper N (2009) Gorham-Stout syndrome with chylothorax: successful remission by interferon alph-2b. Pediatr Pulmonol 44(6):613–615. doi:10.1002/ppul.20849 CrossRefPubMed Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, Gulhan B, Demiricin M, Kiper N (2009) Gorham-Stout syndrome with chylothorax: successful remission by interferon alph-2b. Pediatr Pulmonol 44(6):613–615. doi:10.​1002/​ppul.​20849 CrossRefPubMed
58.
go back to reference Hopmman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH (2012) PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A(7):1719–23. doi:10.1002/ajmg.a.35406 Hopmman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH (2012) PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A(7):1719–23. doi:10.​1002/​ajmg.​a.​35406
Metadata
Title
Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature
Authors
Yi Liu
Ding-Rong Zhong
Pei-Ran Zhou
Fang Lv
Dou-Dou Ma
Wei-Bo Xia
Yan Jiang
Ou Wang
Xiao-Ping Xing
Mei Li
Publication date
01-03-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2780-2

Other articles of this Issue 3/2016

Clinical Rheumatology 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.